BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16740708)

  • 1. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.
    Schnepp RW; Chen YX; Wang H; Cash T; Silva A; Diehl JA; Brown E; Hua X
    Cancer Res; 2006 Jun; 66(11):5707-15. PubMed ID: 16740708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.
    Bai F; Pei XH; Nishikawa T; Smith MD; Xiong Y
    Mol Cell Biol; 2007 Feb; 27(4):1495-504. PubMed ID: 17145768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c.
    Karnik SK; Hughes CM; Gu X; Rozenblatt-Rosen O; McLean GW; Xiong Y; Meyerson M; Kim SK
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14659-64. PubMed ID: 16195383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
    Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
    Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p27
    Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
    J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
    Lindberg D; Akerström G; Westin G
    Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
    Lindberg D; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of p27(Kip1) expression in insulinomas developed in pancreatic beta-cell specific Men1 mutant mice.
    Fontanière S; Casse H; Bertolino P; Zhang CX
    Fam Cancer; 2006; 5(1):49-54. PubMed ID: 16528608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated expression of menin and p27 (Kip1) in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumor.
    Ishida E; Yamada M; Horiguchi K; Taguchi R; Ozawa A; Shibusawa N; Hashimoto K; Satoh T; Yoshida S; Tanaka Y; Yokota M; Tosaka M; Hirato J; Yamada S; Yoshimoto Y; Mori M
    Endocr J; 2011; 58(4):287-96. PubMed ID: 21441703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers.
    Pei XH; Bai F; Smith MD; Xiong Y
    Cancer Res; 2007 Apr; 67(7):3162-70. PubMed ID: 17409423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.
    Lejonklou MH; Barbu A; Stålberg P; Skogseid B
    Endocrinology; 2012 Jun; 153(6):2588-98. PubMed ID: 22492302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-24 regulates menin in the endocrine pancreas.
    Vijayaraghavan J; Maggi EC; Crabtree JS
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(1):E84-92. PubMed ID: 24824656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between menin and Dnmt1 reversibly regulates pancreatic cancer cell growth downstream of the Hedgehog signaling pathway.
    Cheng P; Wang YF; Li G; Yang SS; Liu C; Hu H; Jin G; Hu XG
    Cancer Lett; 2016 Jan; 370(1):136-44. PubMed ID: 26454216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role and mechanism of high expression of cyclin B2 in MEN1 insulinoma].
    Wu T; Huang XH
    Sheng Li Xue Bao; 2011 Dec; 63(6):555-64. PubMed ID: 22193451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.
    Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE
    Cancer Res; 2007 May; 67(10):4732-41. PubMed ID: 17510401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic evidence for functional dependency of p18Ink4c on Cdk4.
    Pei XH; Bai F; Tsutsui T; Kiyokawa H; Xiong Y
    Mol Cell Biol; 2004 Aug; 24(15):6653-64. PubMed ID: 15254233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global expression profiling of murine MEN1-associated tumors reveals a regulatory role for menin in transcription, cell cycle and chromatin remodelling.
    Mould AW; Duncan R; Serewko-Auret M; Loffler KA; Biondi C; Gartside M; Kay GF; Hayward NK
    Int J Cancer; 2007 Aug; 121(4):776-83. PubMed ID: 17455252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis.
    Joshi PP; Kulkarni MV; Yu BK; Smith KR; Norton DL; van Veelen W; Höppener JW; Franklin DS
    Oncogene; 2007 Jan; 26(4):554-70. PubMed ID: 16953232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The negative cell cycle regulators, p27(Kip1), p18(Ink4c), and GSK-3, play critical role in maintaining quiescence of adult human pancreatic β-cells and restrict their ability to proliferate.
    Stein J; Milewski WM; Dey A
    Islets; 2013; 5(4):156-69. PubMed ID: 23896637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
    Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
    Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.